Kouki Hoshino

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Combination Therapy

Skeletal Muscle

Prognostic Factors

Top Venues

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Mariko Tsukagoshi, Kenichiro Araki, Takamichi Igarashi, Norihiro Ishii, Shunsuke Kawai, Kei Hagiwara, Kouki Hoshino, Takaomi Seki, Takayuki Okuyama, Ryosuke Fukushima, Norifumi Harimoto, Ken Shirabe
Lower Geriatric Nutritional Risk Index and Prognostic Nutritional Index Predict Postoperative Prognosis in Patients with Hepatocellular Carcinoma. Nutrients 16 (7) (2024)
Mariko Tsukagoshi, Kenichiro Araki, Takamichi Igarashi, Norihiro Ishii, Shunsuke Kawai, Kei Hagiwara, Kouki Hoshino, Takaomi Seki, Takayuki Okuyama, Ryosuke Fukushima, Norifumi Harimoto, Ken Shirabe
Lower Geriatric Nutritional Risk Index and Prognostic Nutritional Index Predict Postoperative Prognosis in Patients with Hepatocellular Carcinoma. Nutrients 16 (7) (2024)
Takahiro Yamanaka, Norifumi Harimoto, Takehiko Yokobori, Ryo Muranushi, Kouki Hoshino, Kei Hagiwara, Dolgormaa Gantumur, Tadashi Handa, Norihiro Ishii, Mariko Tsukagoshi, Takamichi Igarashi, Akira Watanabe, Norio Kubo, Kenichiro Araki, Kazuo Umezawa, Ken Shirabe
Conophylline Inhibits Hepatocellular Carcinoma by Inhibiting Activated Cancer-associated Fibroblasts Through Suppression of G Protein-coupled Receptor 68. Molecular cancer therapeutics 20 (6) (2021)
Mariko Tsukagoshi, Norifumi Harimoto, Kenichiro Araki, Norio Kubo, Akira Watanabe, Takamichi Igarashi, Norihiro Ishii, Takahiro Yamanaka, Kei Hagiwara, Kouki Hoshino, Ryo Muranushi, Toshiki Yajima, Ken Shirabe
Skeletal Muscle Loss and Octogenarian Status Are Associated with S-1 Adjuvant Therapy Discontinuation and Poor Prognosis after Pancreatectomy. Cancers 13 (16) (2021)